Shaped Around You

During drug development, it is critical to balance risk with time and costs. We understand the complexity of building such optimal paths. By offering flexibility on your journey to IND, we can shape our process around your molecule’s profile, critical milestones and company’s needs.

Our flexibility extends to commercial terms, enhanced portability and specific program guarantees. Giving you even more reasons to choose Lonza. The people powering biologics.

3 Reasons to Partner with Lonza

Whitepaper: Lonza Shapes Biotherapeutics Development Programs Around Different CMC Path

As protein engineering and manufacturing technologies evolve, small biotech and major pharma companies alike need flexible, customized strategies that balance cost, speed and risk to accelerate drug development and approval of biotherapeutics that could address unmet medical needs. 

Read whitepaper 

Knowledge Center
Related Insights
Case studies

Small biotechs who chose to partner with us

In the time since this project began, Lonza added its Hayward, California, and Visp, Switzerland sites, so it’s clear there is an effort to offer flexibility and global capacity to serve the innovation coming out of small biotechs.

— William B. Jones, Senior Vice President of Pharmaceutical Development at Corvus Pharmaceuticals

Mammalian Offerings Catalog